Efficient Mucosal Delivery of Vaccine Using the FcRn-Mediated IgG Transfer Pathway

Vaccine strategies to prevent invasive mucosal pathogens are being sought because 80–90% of infectious diseases are initiated at mucosal surfaces. However, our ability to deliver an intact vaccine antigen across a mucosal barrier for induction of effective immunity is limited. The neonatal Fc recept...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Lilin, Zeng, Rongyu, Bai, Yu, Roopenian, Derry C., Zhu, Xiaoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3197702/
https://www.ncbi.nlm.nih.gov/pubmed/21240266
http://dx.doi.org/10.1038/nbt.1742

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3197702/
https://www.ncbi.nlm.nih.gov/pubmed/21240266
http://dx.doi.org/10.1038/nbt.1742

Ejemplares similares